VaxArray Immunoassay for the Multiplexed Quantification of Poliovirus D-Antigen

BioRxiv : the Preprint Server for Biology
Erica D DawsonK. L. Rowlen

Abstract

Next generation poliovirus vaccines are critical to reaching global poliovirus eradication goals. Recent efforts have focused on creating inactivated vaccines using attenuated Sabin strains that maintain patient safety benefits and immunogenicity of conventional inactivated vaccines while increasing manufacturing safety and lowering production costs, and on developing novel oral vaccines using modified Sabin strains that provide critical mucosal immunity but are further attenuated to minimize risk of reversion to neurovirulence. In addition, there is a push to improve the analytical tools for poliovirus vaccine characterization. Conventional and Sabin inactivated poliovirus vaccines typically rely on standard plate-based ELISA as in vitro D-antigen potency assays in combination with WHO international standards as calibrants. While widely utilized, the current D-antigen ELISA assays have a long time to result (up to 72 hours), can suffer from lab-to-lab inconsistency due to non-standardized protocols and reagents, and are inherently singleplex. For D-antigen quantitation, we have developed the VaxArray Polio Assay Kit, a multiplexed, microarray-based immunoassay that uses poliovirus-specific human monoclonal antibodies currently...Continue Reading

Methods Mentioned

BETA
ELISA
Assay
ELISAs
thermal treatment

Software Mentioned

VaxArray

Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

Biotechnology
V R Racaniello
American Practitioner and Digest of Treatment
R BATSON
The Medical Annals of the District of Columbia
W A HOWARD
JAMA : the Journal of the American Medical Association
M D ADAM, R C SHERETZ
© 2021 Meta ULC. All rights reserved